Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how microfluidic qPCR bridges the gap between traditional qPCR and sequencing, enabling biomarker research, target validation, and more informed development decisions. | Modern drug development demands faster, more scalable gene expression insights. Download this white paper to explore how microfluidic qPCR bridges the gap between traditional qPCR and sequencing, enabling biomarker research, target validation, and more informed development decisions.

In 2017, a little-known company called Nanjing Legend Biotech walked into the ASCO annual meeting at the 11th hour, dropped a 100% objective response rate for a cell therapy that…

New guidance for gene therapy developers, Lilly's deal for kidney drugs, and more biotech news from The Readout